Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis

Overview

Journal Case Rep Rheumatol

Publisher Wiley

Date 2013 Apr 11

PMID 23573450

Citations 4

Authors

Helen Defty

Edward Sames

Teresa Doherty

Rodney Hughes

Affiliations

Soon will be listed here.

Abstract

Etanercept is a monoclonal antibody targeted against Tumour Necrosis Factor-alpha (TNF-a) which is an effective treatment for rheumatoid arthritis and is in cases where conventional disease modifying agents such as methotrexate have failed. Neurological complications of treatment have been documented. We describe a case of transverse myelitis occurring in a 48 year-old lady with RA since 1994 who had been receiving etanercept for four years.

Citing Articles

An Uncommon Overlap Syndrome Between Ankylosing Spondylitis and Amyotrophic Lateral Sclerosis-Case Report.

Banciu C, Chiriac S, Pojoga C, Marian L, Fabian A, Gogulescu A Medicina (Kaunas). 2024; 60(10).

PMID: 39459490 PMC: 11509627. DOI: 10.3390/medicina60101703.

Gritsch D, Valencia-Sanchez C Front Neurol. 2022; 13:1003270.

PMID: 36247761 PMC: 9557103. DOI: 10.3389/fneur.2022.1003270.

Case report: "an unexpected origin of coma in a young adult".

Chandrikasing R, Ramnarain S, Bansie R, Yang H, Ponssen H, Ramdhani N Int J Emerg Med. 2021; 14(1):70.

PMID: 34837945 PMC: 8903714. DOI: 10.1186/s12245-021-00390-5.

CNS Demyelination with TNF-α Blockers.

Kemanetzoglou E, Andreadou E Curr Neurol Neurosci Rep. 2017; 17(4):36.

PMID: 28337644 PMC: 5364240. DOI: 10.1007/s11910-017-0742-1.

References

Tristano A . Neurological adverse events associated with anti-tumor necrosis factor α treatment. J Neurol. 2010; 257(9):1421-31. DOI: 10.1007/s00415-010-5591-7. View

Lees C, Ali A, Thompson A, Ho G, Forsythe R, Marquez L . The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up. Aliment Pharmacol Ther. 2009; 29(3):286-97. DOI: 10.1111/j.1365-2036.2008.03882.x. View

Stubgen J . Tumor necrosis factor-alpha antagonists and neuropathy. Muscle Nerve. 2007; 37(3):281-92. DOI: 10.1002/mus.20924. View

Alshekhlee A, Basiri K, Miles J, Ahmad S, Katirji B . Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists. Muscle Nerve. 2010; 41(5):723-7. DOI: 10.1002/mus.21584. View

Bernatsky S, Renoux C, Suissa S . Demyelinating events in rheumatoid arthritis after drug exposures. Ann Rheum Dis. 2009; 69(9):1691-3. DOI: 10.1136/ard.2009.111500. View